Home
Adjuvant Capital Management, 10% Owner: AN2 Therapeutics ANTX Sell · Filed 23/09/29
Trade details
- Type
- Insider sale
- Amount
- $115,347.6
- Shares · price
- 7,160 sh · $16.11 a share
- Held after
- 2,169,680 sh
- Trade date
- 23/09/28
- Filed
- 23/09/29
- Days to filing
- 1 days
Sold 0.3% of holdings
- Share of holding sold
- 0.3%
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 23/08/29~23/10/28Adjuvant Capital Management's recent trades
- Adjuvant Capital Management
SellAN2 Therapeutics
SellAN2 Therapeutics
ANTX
$1.7M
84,093 sh
$1.7M
Filed 24/01/18
Traded 24/01/16
- Adjuvant Capital Management
SellAN2 Therapeutics
SellAN2 Therapeutics
ANTX
$312.6K
15,907 sh
$312.6K
Filed 24/01/18
Traded 24/01/16
- Adjuvant Capital Management
Sell10b5-1 planAN2 Therapeutics
Sell10b5-1 planAN2 Therapeutics
ANTX
$24.6K
1,522 sh
$24.6K
Filed 23/11/16
Traded 23/11/14
- Adjuvant Capital Management
Sell10b5-1 planAN2 Therapeutics
Sell10b5-1 planAN2 Therapeutics
ANTX
$4,651
288 sh
$4,651
Filed 23/11/16
Traded 23/11/14
- Adjuvant Capital Management
SellAN2 Therapeutics
SellAN2 Therapeutics
ANTX
$1.4M
83,337 sh
$1.4M
Filed 23/10/03
Traded 23/09/29